EDGAR Filing Documents for 0001140361-09-018340

Form 8-K - Current report:

SEC Accession No. 0001140361-09-018340

Filing Date

2009-08-10

Accepted

2009-08-10 06:07:18

Documents

Period of Report

2009-08-10

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	REXAHN PHARMACEUTICALS INC 8-K 8-10-2009	form8k.htm	8-K	48836
2	EXHIBIT 10.1	ex10_1.htm	EX-10.1	105444
3	EXHIBIT 10.2	ex10_2.htm	EX-10.2	104419
4	EXHIBIT 10.3	ex10_3.htm	EX-10.3	104338
5	EXHIBIT 99.1	ex99_1.htm	EX-99.1	12939
6		rexahnlogosm.jpg	GRAPHIC	3162
	Complete submission text file	0001140361-09-018340.txt		382313

Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850

Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300

REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)